title: Fertilization efficiency of morphologically abnormal spermatozoa in assisted reproduction is further impaired by antisperm antibodies on the male partner's sperm.
abstract: OBJECTIVE
  To investigate the influence of antisperm antibodies on the sperm surface on the outcome of IVF and GIFT.
  
  
  METHODS
  Matched controlled retrospective review of two large series.
  
  
  METHODS
  Reproductive endocrine divisions of two level-three academic centers.
  
  
  METHODS
  Twenty-nine male factor patients (38 IVF cycles) showing positive antisperm antibodies on the sperm by immunobead test treated by IVF at the Norfolk program and 56 similar patients (57 cycles) treated by GIFT at the Tygerberg program. Twenty-nine male factor patients (29 IVF cycles) with negative antisperm antibodies screening matched by wife's stimulation protocol and baseline semen analysis characteristics were used as controls in Norfolk; 56 GIFT patients (56 GIFT cycles) matched similarly were the Tygerberg controls. Study and control groups were divided according to sperm morphology pattern in normal, good, and poor prognosis subgroups for comparison.
  
  
  METHODS
  Fertilization rate of preovulatory oocytes used in IVF in Norfolk and of GIFT supernumerary preovulatory oocytes in Tygerberg; total and term pregnancy rates (PRs) and abortion rates.
  
  
  RESULTS
  Fertilization rate was significantly lower in the IVF (41.9% +/- 2.8%) as well as in the GIFT (26.8% +/- 3.8%) (mean +/- SE) study groups than in the respective control groups (73.1% +/- 3.9% and 61.8% +/- 3.9%). Total and term PRs in IVF per cycle (21.1% +/- 6.6%; 13.2% +/- 5.5%) and per transfer (23.5% +/- 7.4%; 14.7% +/- 6.1%), and in GIFT (25.0% +/- 5.8%; 19.6% +/- 5.3%) in the study groups were also lower when compared with their control counterparts (IVF per cycle: 62.1% +/- 6.2% and 41.4% +/- 6.0%; IVF per transfer: 41.9% +/- 2.0% and 27.9% +/- 1.9%; GIFT: 31.6% +/- 6.2% and 28.1% +/- 6.0%), but the difference did not reach statistical significance. Abortion rates were similar in the IVF study group (37.5% +/- 17.1%) and its control groups (39.9% +/- 11.5%). The abortion rate in the GIFT study group was 14.3% +/- 9.4%, and no abortions were recorded in the control group (not significant).
  
  
  CONCLUSIONS
  The presence of antisperm antibodies on the sperm surface per se impairs the outcome of assisted reproduction, mainly in terms of fertilization rate of preovulatory oocytes, and possibly in terms of total and term PRs. This holds true regardless of the impact of other semen parameters, particularly the morphology of the sperm within the semen sample.
authors.affiliation: Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk 23507.
authors.forename: A A
authors.initials: AA
authors.lastname: Acosta
authors.forename: J P
authors.initials: JP
authors.lastname: van der Merwe
authors.forename: G
authors.initials: G
authors.lastname: Doncel
authors.forename: T F
authors.initials: TF
authors.lastname: Kruger
authors.forename: A
authors.initials: A
authors.lastname: Sayilgan
authors.forename: D R
authors.initials: DR
authors.lastname: Franken
authors.forename: P
authors.initials: P
authors.lastname: Kolm
mesh_terms: D000022:Abortion, Spontaneous / Q000453:epidemiology; D000906:Antibodies / Q000032:analysis / Q000502:physiology*; D005260:Female; D005306:Fertilization; D005307:Fertilization in Vitro; D015181:Gamete Intrafallopian Transfer; D006801:Humans; D015994:Incidence; D008297:Male; D011247:Pregnancy; D012189:Retrospective Studies; D013094:Spermatozoa / Q000002:abnormalities* / Q000276:immunology*
chemical_list: D000906:Antibodies